Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today advises that, as previously ...

GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, is proud to ...

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

The Greater New Orleans region is making significant strides in advancing healthcare through innovative research, ...

Among patients with acute LBP, use of nonpharmacologic therapy was associated with reduced risk for overdose-related hospitalizations.

Memorial Day is a solemn occasion to honor the men and women who made the ultimate sacrifice in service to our nation. We ...

Keep the Party Safe, developed at CU Anschutz, has distributed 8,500 doses of naloxone and 1,800 fentanyl test strips at over ...

A randomized trial found that interdisciplinary care models modestly improved pain and significantly reduced opioid use in ...

Nonbenzodiazepine MRs may improve pain, muscle spasms, and physical outcomes compared with placebo in adults with acute LBP.